American Economic Planning Group’s AbbVie ABBV Stock Holding History

American Economic Planning Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,933	Closed	-$213K	–	90
2019 Q2	$213K	Buy	2,933 +47	+2%	+$3.69K	0.06%	87
2019 Q1	$233K	Buy	2,886 +197	+7%	+$16.1K	0.07%	79
2018 Q4	$248K	Sell	2,689 -219	-8%	-$19.3K	0.08%	67
2018 Q3	$275K	Sell	2,908 -103	-3%	-$9.77K	0.1%	58
2018 Q2	$279K	Buy	3,011 +403	+15%	+$39.4K	0.1%	60
2018 Q1	$247K	Buy	2,608 +94	+4%	+$10.3K	0.09%	75
2017 Q4	$243K	Sell	2,514 -22	-0.9%	-$2.07K	0.09%	71
2017 Q3	$225K	Buy	+2,536	New	+$193K	0.08%	73

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

American Economic Planning Group's ABBV Position: Q3 2019 in Review

American Economic Planning Group sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 2,933 shares — an estimated $213K sold.

American Economic Planning Group first reported a position in ABBV in Q3 2017 and held it in 8 quarters. The position peaked at $279K in Q2 2018. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

American Economic Planning Group reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
American Economic Planning Group sold 2,933 AbbVie shares in Q3 2019, an estimated $213K.
American Economic Planning Group first reported a position in AbbVie in Q3 2017 and held it in 8 quarters.
American Economic Planning Group's AbbVie position peaked at $279K in Q2 2018.
2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on American Economic Planning Group's 13F filing for Q3 2019, filed 9 Oct 2019.